New combo aims to stall sarcomas in tough cases
NCT ID NCT05182164
First seen Nov 01, 2025 · Last updated Jun 18, 2026 · Updated 27 times
Summary
This study tests two drugs, pembrolizumab and cabozantinib, together in people with advanced sarcomas (cancers of the soft tissue or bone) that have not responded to standard treatments. The goal is to see if the combination can stop or shrink tumors for at least 6 months. About 119 adults with specific sarcoma types will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOSARCOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Centre Georges François Leclerc
RECRUITINGDijon, 21079, France
Contact Email: •••••@•••••
-
Centre Leon Berard
NOT_YET_RECRUITINGLyon, 69008, France
Contact Email: •••••@•••••
-
Centre Oscar Lambret
NOT_YET_RECRUITINGLille, 59020, France
Contact Email: •••••@•••••
-
Hôpital La Timone
RECRUITINGMarseille, 13385, France
Contact Email: •••••@•••••
-
IUCT Oncopole
NOT_YET_RECRUITINGToulouse, 31059, France
Contact Email: •••••@•••••
-
Institut Bergonie
RECRUITINGBordeaux, 33076, France
Contact Email: •••••@•••••
Contact Email: •••••@•••••
-
Institut Curie
NOT_YET_RECRUITINGParis, 75248, France
Contact Email: •••••@•••••
-
Institut Gustave Roussy
RECRUITINGVillejuif, 94805, France
Contact Email: •••••@•••••
-
Institut Paoli Calmettes
RECRUITINGMarseille, 13009, France
Contact Email: •••••@•••••
-
Institut de Cancérologie de l'Ouest - Site René Gauducheau
RECRUITINGSaint-Herblain, 44805, France
Contact Email: •••••@•••••
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.